PROVECTUS BIOPHARMACEUTICALS, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
800 S. GAY STREET, KNOXVILLE, TN, 37929
Mailing Address
800 S. GAY STREET, KNOXVILLE, TN, 37929
Phone
(866) 594-5999
Fiscal Year End
1231
EIN
900031917
Financial Overview
FY2025
-$5.96M
Stockholders' Equity
$-0.01
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 6, 2026 | View on SEC |
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 26, 2026
- Advanced clinical-stage pipeline featuring lead drug candidate PV-10 for solid tumors.
- Strong intellectual property portfolio with over 60 global patents secured.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.